Market Report · May 18, 2026
Report Feature
The future of the soft tissue allograft market looks promising with opportunities in orthopedic, dentistry, and wounded care applications. The global soft tissue allograft market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing demand for soft tissue allografts in athletics and other contact sports, increase in incidences of periodontal diseases among the young population, and rise in technological innovations in dental.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global soft tissue allograft market report, please download the report brochure.
In this market, cartilage allograft is the largest product segment of soft tissue allograft, whereas dentistry is the largest application. Growth in various segments of the soft tissue allograft market are given below:
The study includes trends and forecast for the global soft tissue allograft market by product type, application, end user, and region as follows:
By Product Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cartilage Allograft
- Tendon Allograft
- Meniscus Allograft
- Dental Allograft
- Collagen Allograft
- Amniotic Allograft
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Orthopedic
- Dentistry
- Wounded Care
- Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Orthopedic Clinics
- Dental Clinics
- Ambulatory Service Centers
- Aesthetic Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the soft tissue allograft companies profiled in this report include Arthrex, Zimmer Biomet, Integra LifeSciences Corporation, Lattice Biologics, Organogenesis, CONMED, Straumann, Osiris Therapeutics, Globus Medical, Alliqua BioMedical, Xtant Medical, B. Braun Melsungen, and C. R. Bard.
Lucintel forecasts that cartilage allograft will remain the largest product type segment over the forecast period due to increase in vascular and orthopedic surgeries, ACL surgeries, and other cosmetic surgeries.
Within this market, dentistry will remain the largest application segment over the forecast period, as soft tissue allograft are used to stop gum recession and to improve the appearance of the same. Soft tissues are also beneficial in curing periodontal disease and improve gum aesthetics.
North America will remain the largest region over the forecast period due to factors, such as increasing prevalence of diabetic foot ulcers, better healthcare awareness programs for diabetes, an increase in a number of surgical procedures on anterior cruciate ligament (ACL), technological development in dental implants, and increasing expenditure by major & small key players for the development of soft tissue allograft in the region.
|
Features of the Global Soft Tissue Allograft Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global soft tissue allograft by product type (cartilage allograft, tendon allograft, meniscus allograft, dental allograft, collagen allograft, and amniotic allograft), application (orthopedic, dentistry, wounded care, and others), end user (hospitals, orthopedic clinics, dental clinics, ambulatory service centers, and aesthetic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global soft tissue allograft market? Q.5 What are the business risks and threats to the global soft tissue allograft market? Q.6 What are the emerging trends in this soft tissue allograft market and the reasons behind them? Q.7 What are some changing demands of customers in this soft tissue allograft market? Q.8 What are the new developments in this soft tissue allograft market? Which companies are leading these developments? Q.9 Who are the major players in this soft tissue allograft market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this soft tissue allograft market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global soft tissue allograft market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft), Application (Orthopedic, Dentistry, Wounded Care, and Others), and End User (Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers), |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Soft Tissue Allograft Market
4.1 Global Soft Tissue Allograft Market by Region
4.2.1 Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
4.2.2 Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
4.2.3 Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
4.2.4 The United States Soft Tissue Allograft Market
4.2.5 The Canadian Soft Tissue Allograft Market
4.2.6 The Mexican Soft Tissue Allograft Market
4.3.1 Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
4.3.2 Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
4.3.3 Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
4.3.4 The United Kingdom Soft Tissue Allograft Market
4.3.5 The Spanish Soft Tissue Allograft Market
4.3.6 The German Soft Tissue Allograft Market
4.3.7 The French Soft Tissue Allograft Market
4.4.1 Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
4.4.2 Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
4.4.3 Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
4.4.4 The Chinese Soft Tissue Allograft Market
4.4.5 The Indian Soft Tissue Allograft Market
4.4.6 The Japanese Soft Tissue Allograft Market
4.5.1 Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
4.5.2 Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
4.5.3 Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
4.5.4 Brazilian Soft Tissue Allograft Market
7.1.1 Growth Opportunities for the Global Soft Tissue Allograft Market by Product Type
7.1.2 Growth Opportunities for the Global Soft Tissue Allograft Market by Application
7.1.3 Growth Opportunities for the Global Soft Tissue Allograft Market by End User
7.1.4 Growth Opportunities for the Global Soft Tissue Allograft Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
